Photo of ENDRA management, Board, key investors, banking partners and family members.

Investor Overview

ENDRA’s mission is to bring new capabilities to ultrasound. ENDRA’s photo-acoustic solutions currently help global medical researchers screen and modify disease models with high image quality and volume scanning speed. ENDRA has a global installed base of leading institutions using the Nexus 128 system, a fully 3D photoacoustic imaging solution for imaging anatomy, physiology and labeled molecular targets.

Building on its expertise in thermo-acoustics, ENDRA has developed a next generation technology platform — Thermo Acoustic Enhanced Ultrasound, or TAEUS — which is intended to enhance the capability of clinical ultrasound technology and support the diagnosis and treatment of a number of significant medical conditions that currently require the use of expensive CT or MRI imaging or where imaging is not practical using existing technology.

ENDRA’s thermo-acoustic technology is being developed to enable clinicians to use their existing ultrasound equipment to clearly visualize tissue function, composition, and monitor a variety of therapeutic interventions – at the point of care. This directly aligns with current healthcare trends to improve patient access, clinical effectiveness, safety and cost.

Quick Links

Investor Presentation: Bringing New Capabilities To Ultrasound 10-Q
Third Quarter 2017 Results Conference Call

Latest News

All News

Latest Events

All Events